Engagement Through Investor Conferences
Lantheus Holdings, Inc. (NASDAQ: LNTH), a leading company in the radiopharmaceutical sector, is dedicated to empowering clinicians in their pursuit to Find, Fight, and Follow disease. To further enrich its investor relations, Lantheus has announced its participation in several upcoming investment conferences.
Details of Conferences
B. Riley Securities Precision Oncology & Radiopharma Day
This event will be held in New York, facilitating discussions around precision oncology and radiopharmaceutical advancements. Attending will allow Lantheus to showcase its latest innovations and strategic initiatives directed toward enhancing patient outcomes.
TD Cowen 45th Annual Health Care Conference
Scheduled for March 4, this conference will feature key speakers from Lantheus discussing current developments and future prospects. The live presentation at 2:30 PM ET promises to deliver insightful information for potential investors and healthcare stakeholders.
Leerink Global Healthcare Conference 2025
On March 11, Lantheus will present at the Leerink Global Healthcare Conference in Miami. This pivotal event will highlight the company's ongoing commitment to innovation in radiopharmaceuticals, furthering the dialogue on improving patient treatment options.
Webcast and Replay Availability
For those unable to attend in person, a live webcast will be available for both the TD Cowen and Leerink conferences on the company's website. This ensures investors, clinicians, and interested parties can follow the discussions and insights shared during these key presentations. Furthermore, recordings of the webcasts will be accessible for at least 30 days post-event.
About Lantheus Holdings
Lantheus has established itself as a frontrunner in the field of radiopharmaceuticals. With over 65 years of experience, the company operates from its headquarters in Massachusetts, complemented by offices in Canada and Sweden. Lantheus's mission is to deliver transformative science that aids healthcare professionals in diagnosing and treating diseases more effectively.
Contact Information
For more details about the upcoming conferences or to engage with company representatives, investors and media can reach out to the following contacts:
Mark Kinarney
Vice President, Investor Relations
Phone: 978-671-8842
Email: ir@lantheus.com
Melissa Downs
Senior Director, External Communications
Phone: 646-975-2533
Email: media@lantheus.com
Frequently Asked Questions
What conferences is Lantheus Holdings participating in?
Lantheus is participating in the B. Riley Securities Precision Oncology & Radiopharma Day, TD Cowen Annual Health Care Conference, and the Leerink Global Healthcare Conference.
How can I access the live webcasts?
The live webcasts will be available on Lantheus's website during the respective conference presentations.
What is the mission of Lantheus Holdings?
Lantheus aims to empower clinicians with radiopharmaceutical solutions to improve patient care and outcomes.
How long will the webcasts be available for replay?
Recordings of the webcasts will be accessible for at least 30 days after the live presentations.
Who can I contact for investor relations information?
Contact Mark Kinarney, Vice President of Investor Relations, via email at ir@lantheus.com or by phone at 978-671-8842.
